This session explores the rise of AFPs and specialty carve Outs, analyzing how these programs affect the pharmaceutical landscape, patient affordability and access to specialty medications. Speakers will discuss the legal, regulatory and financial ramifications that AFPs pose for consumers and employers and provide insight on potential regulatory efforts that can mitigate the impact of these programs.

• Explore how pharma can utilize EHR systems to gain deeper market insights, streamline payer negotiations and enhance real-world evidence for drug access strategies

• Leverage EHR data to support reimbursement, improve formulary positioning and foster collaborations with healthcare providers for better commercial outcomes

• Foster stronger collaboration between pharma and payers to eliminate redundancies, reduce administrative burdens and enhance the efficiency of patient navigation

• Evaluate a unified digital health approach to improve adherence, streamline communication and ensure quicker access to therapies, ultimately driving better patient outcomes

• Break down barriers between pharma, payers and healthcare providers, creating a frictionless experience that accelerates treatment access and improves the patient journey from diagnosis to therapy

As AFPs increasingly divert patients away from traditional coverage models, pharmaceutical companies must develop strategies to safeguard patient access to essential treatments. This session focuses on building robust patient assistance programs, collaborating with payers and ensuring compliance, while addressing the challenges posed by Specialty Carve Outs, including how AFP’s are evolving heir business models and tactics based on observations.

• Capitalize on EHR data to refine their commercial strategies and optimize market entry and expansion efforts

• Focus on how integrating EHR insights into market access planning can help forecast demand, identify treatment gaps and provide data-driven support for pricing, contracting and distribution strategies